We only have this paper's title and publication details.
Read it at the sourceAssay validation demonstrates analytical performance of second-generation ORF1p Simoa assays, highlighting utility for ultrasensitive multicancer biomarker detection.
Assay validation for second-generation ORF1p Simoa assays.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: